Thymosin Alpha-1 (Tα1)
Research-Grade Immunomodulatory Peptide
Tagline: Immune System & Inflammation Research
Product Description
Thymosin Alpha-1 (Tα1) is a 28–amino acid peptide fragment derived from the thymic hormone prothymosin alpha. It is a potent immunomodulatory molecule that enhances both innate and adaptive immune responses.
Researchers use Tα1 in preclinical and in vitro studies to explore immune activation, T-cell function, antiviral defense, and tumor immunology. It is widely studied for its potential to regulate immune tolerance, modulate cytokine production, and restore immune balance in immune-suppressed states.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose Thymosin Alpha-1
-
Immune Activation: Enhances T-cell differentiation and NK cell activity.
-
Broad Research Relevance: Studied in infection, cancer immunology, and vaccine adjuvant research.
-
Cytokine Modulation: Promotes Th1 response, increases IFN-γ production.
-
Well-Characterized Peptide: Clinically investigated, with decades of published data.
-
Batch Verified: ≥98% purity, identity confirmed by HPLC and mass spectrometry.
Important Note
For laboratory and scientific research only. Not for human consumption, therapeutic, or diagnostic use.
